BINEX Co. Ltd

053030 • KQ

₩7,300.00₩0.00 (0%)

Estimate

Beta

0.693

Growth

Revenue, YoY

-11.24%

Net income, YoY

-77,790.48%

FCF, YoY

53.54%

Forecast

P/E (FWD)

53.3

EPS (FWD)

136.86

About the company

Ticker

053030

ISIN

KR7053030003

Country

South Korea

Sector (GICS)

Healthcare

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.

Frequently asked questions

What sector does BINEX Co. Ltd (053030) operate in?

BINEX Co. Ltd belongs to the Healthcare sector and operates in the Pharmaceuticals industry.

What is BINEX Co. Ltd (053030) current stock price?

As of the latest data, BINEX Co. Ltd stock price is ₩7,300, with a previous close of ₩7,300.

What is BINEX Co. Ltd (053030) current market capitalization?

BINEX Co. Ltd market cap is approximately 227.67 billion.

Does BINEX Co. Ltd (053030) pay dividends?

No. BINEX Co. Ltd does not pay a dividend.

What is BINEX Co. Ltd (053030) beta (volatility) score?

BINEX Co. Ltd has a beta of 0.693, indicating lower volatility than the overall market.